Aspen Aerogels (NYSE:ASPN) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPS

Aspen Aerogels (NYSE:ASPN) released its quarterly earnings results on Thursday. The construction company reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.27) by ($0.01), FiscalAI reports. The company had revenue of $37.88 million for the quarter, compared to the consensus estimate of $36.58 million. Aspen Aerogels had a negative return on equity of 20.79% and a negative net margin of 48.64%.The business’s revenue was down 51.8% compared to the same quarter last year. During the same quarter last year, the company posted ($0.06) EPS. Aspen Aerogels updated its Q2 2026 guidance to -0.240–0.17 EPS.

Here are the key takeaways from Aspen Aerogels’ conference call:

• Management reported an explosion and temporary shutdown at the East Providence plant, with a staged restart expected in May, creating short-term supply disruption and elevated costs from expedited freight and repairs.
• Aspen expects ~20% revenue growth in Energy Industrial for 2026, driven by growing Subsea awards, an anticipated ~2x increase in LNG activity, and maintenance/turnaround opportunities, and aims to scale the segment to a $200M high‑margin business without incremental capex.
• Thermal Barrier momentum is concentrated in Europe—Q1 EU revenue was >3x year‑ago and Aspen targets roughly $10M–$15M from European OEM programs in 2026—while the company is also pursuing battery energy storage system qualifications with potential initial revenue in 2026.
• Q2 guidance calls for revenue of $40M–$48M and Adjusted EBITDA of −$10M to −$4M; liquidity is strong with $175.6M cash (ample covenant headroom), but the company expects possible Q2 cash outflows of $20M–$30M depending on supply mitigation and inventory build.

Aspen Aerogels Stock Performance

NYSE:ASPN traded down $0.07 during mid-day trading on Friday, hitting $5.05. 2,011,581 shares of the company’s stock traded hands, compared to its average volume of 1,828,986. The firm has a 50 day moving average of $3.46 and a two-hundred day moving average of $3.79. Aspen Aerogels has a 12 month low of $2.30 and a 12 month high of $9.78. The firm has a market capitalization of $418.04 million, a price-to-earnings ratio of -3.71 and a beta of 2.83. The company has a current ratio of 3.90, a quick ratio of 3.29 and a debt-to-equity ratio of 0.34.

Institutional Trading of Aspen Aerogels

A number of hedge funds have recently modified their holdings of the company. WINTON GROUP Ltd acquired a new stake in shares of Aspen Aerogels during the 4th quarter worth approximately $40,000. StoneX Group Inc. bought a new stake in shares of Aspen Aerogels during the fourth quarter valued at approximately $41,000. Acadian Asset Management LLC bought a new stake in shares of Aspen Aerogels during the first quarter valued at approximately $43,000. Tower Research Capital LLC TRC increased its position in shares of Aspen Aerogels by 184.6% during the second quarter. Tower Research Capital LLC TRC now owns 7,235 shares of the construction company’s stock valued at $43,000 after purchasing an additional 4,693 shares during the period. Finally, Schonfeld Strategic Advisors LLC bought a new stake in shares of Aspen Aerogels during the fourth quarter valued at approximately $58,000. Institutional investors own 97.64% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on the company. TD Cowen decreased their price target on Aspen Aerogels from $7.00 to $6.00 and set a “buy” rating for the company in a research note on Thursday, February 26th. Zacks Research upgraded Aspen Aerogels from a “strong sell” rating to a “hold” rating in a research note on Thursday, January 15th. Weiss Ratings restated a “sell (d-)” rating on shares of Aspen Aerogels in a research note on Friday, March 27th. Barclays decreased their target price on Aspen Aerogels from $4.00 to $3.00 and set an “underweight” rating for the company in a research note on Thursday, March 5th. Finally, Roth Mkm restated a “buy” rating and set a $5.75 target price on shares of Aspen Aerogels in a research note on Friday. Three analysts have rated the stock with a Buy rating, one has given a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, Aspen Aerogels has a consensus rating of “Hold” and a consensus price target of $4.94.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.